NPC1 inactivation was accomplished either by using the drug U18666A or by CRISPR/R-Cas9 NPC1 gene editing, and cell infection was carried out using a pseudotyped vesicular stomatitis virus (VSV) expressing the SARS-CoV-2 S protein [34]. The gene discussed is NPC1; the disease is infection.